http://www.rxpgnews.com/ Medical News and Information Thu, 21 Aug 2008 02:00:28 PST en-us http://www.rxpgnews.com/research/Doctors-conclude-temsirolimus-is-effective-new-treatment-for-advanced-renal-cell-carcinoma_37325.shtml Latest Research The results of a phase III, randomized clinical study involving patients with advanced renal cell carcinoma and poor prognostic features show temsirolimus improved overall survival when compared to the current treatment for this stage of disease. The study, led by Gary R. Hudes, M.D., director of the Genitourinary Malignancies Program at Fox Chase Cancer Center, is published in the May 31 issue of the New England Journal of Medicine. Fri, 01 Jun 2007 04:00:00 PST http://www.rxpgnews.com/research/Doctors-conclude-temsirolimus-is-effective-new-treatment-for-advanced-renal-cell-carcinoma_37325.shtml http://www.rxpgnews.com/rcc/Renal_cancer_related_to_deficiency_in_exposure_to__4982_4982.shtml Renal Cell Carcinoma Using newly available data on worldwide cancer incidence to map cancer rates in relation to proximity to the equator, researchers at the Moores Cancer Center at University of California, San Diego (UCSD) have shown a clear association between deficiency in exposure to sunlight, specifically ultraviolet B (UVB), and kidney cancer. Tue, 19 Sep 2006 14:53:00 PST http://www.rxpgnews.com/rcc/Renal_cancer_related_to_deficiency_in_exposure_to__4982_4982.shtml http://www.rxpgnews.com/rcc/Sunitinib_malate_more_effective_than_standard_cyto_4374_4374.shtml Renal Cell Carcinoma According to a new study, the drug sunitinib malate is more effective than the current standard cytokine treatment given as an initial therapy for patients with advanced kidney cancer, also known as metastatic renal cell carcinoma (mRCC). Mon, 05 Jun 2006 16:34:00 PST http://www.rxpgnews.com/rcc/Sunitinib_malate_more_effective_than_standard_cyto_4374_4374.shtml http://www.rxpgnews.com/rcc/Bayer_wins_positive_response_for_cancer_drug_4196_4196.shtml Renal Cell Carcinoma Bayer AG said Friday that the company and its US partner Onyx Pharmaceuticals Inc have received a positive response from European officials to their drug to treat kidney cancer. Sun, 30 Apr 2006 19:25:00 PST http://www.rxpgnews.com/rcc/Bayer_wins_positive_response_for_cancer_drug_4196_4196.shtml http://www.rxpgnews.com/rcc/Imatinib_mesylate_is_not_likely_to_be_effective_fo_3034_3034.shtml Renal Cell Carcinoma Mayo Clinic Cancer Center investigators report that imatinib mesylate (GleevecTM), the drug used to treat patients with gastrointestinal stromal cancers (GISTs), is not likely to be effective for patients with high grade renal cell carcinoma -- the most aggressive kidney cancer. Results of the study are published in the January issue of The Journal of Urology. Thu, 22 Dec 2005 05:04:00 PST http://www.rxpgnews.com/rcc/Imatinib_mesylate_is_not_likely_to_be_effective_fo_3034_3034.shtml